Cryo-cadd
CRYO-CADD generates structural insights through an iterative cycle and enables hit-to-lead optimization. It uses structure-guided design to optimize chemical scaffolds into a development candidate.

Gandeeva Therapeutics uses structural imaging to develop precision medicines and support drug discovery.
gandeeva.comCrawled Oct 15, 2026
CRYO-CADD generates structural insights through an iterative cycle and enables hit-to-lead optimization. It uses structure-guided design to optimize chemical scaffolds into a development candidate.
HYPERFOCUS combines experimental data, fragment libraries, and virtual screening to refine and confirm predictions. It identifies druggable targets prioritized by SPOTLIGHT and validated by cryo-EM.
The company’s platform identifies druggable transient protein interactions for the design of precision molecular glues.
SPOTLIGHT is an AI- and cryo-EM-based approach that evaluates and ranks hundreds of predicted protein-protein interactions to identify and structurally validate druggable target-protein interactions.
Gandeeva Therapeutics announced it raised US$40 million in Series A funding led by Lux Capital and Leaps by Bayer, with participation from Obvious Ventures and Amgen Ventures. The company develops therapeutics using cryo-EM and machine learning.
Gandeeva Therapeutics seeks creative leaders, problem solvers, and curious innovators. The company says it offers a flexible, equitable, inclusive, and respectful work environment with opportunities for employee development and growth.
Gandeeva Therapeutics is a biotechnology company in Metro Vancouver, BC, that uses cryo-EM technology to design drugs. It says its methods address limitations of X-ray crystallography and computational docking in drug design.
Pro-Vice Chancellor for Innovation and Professor of Translational Medicine, Oxford University.
Chief Financial Officer
Dean, Faculty of Medicine and Vice-President, Health, University of British Columbia.
Board Observer
Director
Senior Director, Structural Biology and Cryo-EM Operations
Gandeeva Therapeutics, Inc. lists its Seattle address and Canadian operations address in Burnaby, British Columbia.
Gandeeva Therapeutics is a precision medicine company leveraging cryo-EM and machine learning for drug discovery.
This privacy statement was last changed on March 7, 2022, last checked on April 19, 2022, and applies to citizens and legal permanent residents of Canada.
This privacy statement was last updated on March 7, 2022 and applies to citizens and legal permanent residents of the European Economic Area and Switzerland.